TrialHuman molecular genetics2022

A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome.

Siddharth Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.